Conclusively, the present results demonstrate multiple roles of LPA2 in asthmatic responses and suggest that the development of LPA2 antagonists would achieve better therapeutic efficacy against asthma than agonists, although it would be a challenge to develop a therapeutic targeting LPA2. The gene discussed is LPAR2; the disease is asthma.